产品详情
简单介绍:
Anti-e-LOX-3 Antibody
详情介绍:
Overview
Name: | Anti-e-LOX-3 Antibody See all e-LOX-3 primary antibodies
|
Description: | Rabbit polyclonal antibody to e-LOX-3 |
Applications: | WB, IHC |
Reactivity: | Human |
Immunogen: | Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 264 of Human ALOXE3 |
Host: | Rabbit |
Clonality: | Polyclonal |
Conjugate: | Unconjugated |
Purification: | Purified by antigen-affinity chromatography. |
Formulation: | Supplied in 0.1M Tris-buffered saline with 10% Glycerol (pH7.0). 0.01% Thimerosal was added as a preservative. |
Storage: | Store at -20?C for long term preservation (recommended). Store at 4?C for short term use. |
Target
Function: | Non-heme iron-containing lipoxygenase which is atypical in that it displays a prominent hydroperoxide isomerase activity and a reduced dioxygenase activity compared to other lipoxygenases. The hydroperoxide isomerase activity catalyzes the isomerization of hydroperoxides, derived from arachidonic and linoleic acid by ALOX12B, into hepoxilin-type epoxyalcohols. The dioxygenase activity requires a step of activation of the enzyme by molecular oxygen. In presence of oxygen, oxygenates polyunsaturated fatty acids, including arachidonic acid, to produce fatty acid hydroperoxides. In the skin, acts downstream of ALOX12B on the linoleate moiety of esterified omega-hydroxyacyl-sphingosine (EOS) ceramides to produce an epoxy-ketone derivative, a crucial step in the conjugation of omega-hydroxyceramide to membrane proteins. Therefore plays a crucial role in the synthesis of corneocytes lipid envelope and the establishment of the skin barrier to water loss. In parallel, it may have a signaling function in barrier formation through the production of hepoxilins metabolites. Plays also a role in adipocyte differentiation through hepoxilin A3 and hepoxilin B3 production which in turn activate PPARG. Through the production of hepoxilins in the spinal cord, it may regulate inflammatory tactile allodynia. |
Tissue Specificity: | Predominantly expressed in skin. |
Involvement in Disease: | Ichthyosis, congenital, autosomal recessive 3: A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. |
Sequence Similarities: | Belongs to the lipoxygenase family. |
Cellular Location: | Cytoplasm. |
Database Links: |
|
Synonyms: | |
Information: | Target information shown above is from the UniProt Consortium. |
相关文章